NDC 0338-9549 – Clindamycin phosphate
Clindamycin Phosphate 600 mg/50mL · Injection, Solution · Intravenous
Product NDC0338-9549
Product details
- Brand name
- Clindamycin phosphate
- Generic name
- Clindamycin phosphate
- Labeler
- Baxter Healthcare Company
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- NDA · NDA208083
- Marketed since
- April 20, 2017
- Listing expires
- December 31, 2027
- Pharmacologic class
- Lincosamide Antibacterial
Active ingredients
- Clindamycin Phosphate 600 mg/50mL
Uses, dosage, side effects and warnings for Clindamycin phosphate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0338-9549-24 | 24 BAG in 1 CARTON (0338-9549-24) / 50 mL in 1 BAG (0338-9549-50) | Apr 20, 2017 |
Recalls mentioning this NDC
- D-0816-2026 Sep 9, 2026 · Class II
CGMP Deviations
Other Clindamycin phosphate products
- 0338-3410 Clindamycin Phosphate 300 mg/50mL · Injection, Solution · Baxter Healthcare Company
- 0338-3612 Clindamycin Phosphate 600 mg/50mL · Injection, Solution · Baxter Healthcare Company
- 0338-3616 Clindamycin Phosphate 600 mg/50mL · Injection, Solution · Baxter Healthcare Company
- 0338-3814 Clindamycin Phosphate 900 mg/50mL · Injection, Solution · Baxter Healthcare Company
- 0338-4114 Clindamycin Phosphate 900 mg/50mL · Injection, Solution · Baxter Healthcare Company
- 0338-9545 Clindamycin Phosphate 300 mg/50mL · Injection, Solution · Baxter Healthcare Company
- 0338-9553 Clindamycin Phosphate 900 mg/50mL · Injection, Solution · Baxter Healthcare Company
- 43066-995 Clindamycin Phosphate 900 mg/50mL · Injection, Solution · Baxter Healthcare Corporation
- 43066-993 Clindamycin Phosphate 600 mg/50mL · Injection, Solution · Baxter Healthcare Corporation
- 50090-1932 Clindamycin Phosphate 10 mg/mL · Solution · A-S Medication Solutions
- 50090-5779 Clindamycin Phosphate 11.9 mg/mL · Solution · A-S Medication Solutions
- 50090-2611 Clindamycin Phosphate 10 mg/mL · Solution · A-S Medication Solutions